1) Bring your insurance card. If you’re using insurance to pay for your medication, be sure to bring your insurance card. This is especially important at the beginning of the new year when new cards are sent out. Even though many insurance cards look similar from year to year, there may be a slight change
Complete Reading

(HealthDay)—Nutra Pharma Corp. has been warned about illegal marketing of unapproved homeopathic products with claims that they can treat addiction and chronic pain from serious conditions such as cancer, diabetes, shingles, and fibromyalgia, the U.S. Food and Drug Administration says. A warning letter was issued to the company for the products Nyloxin Oral Spray, Nyloxin
Complete Reading

A two-week treatment course for adult patients with chronic Chagas disease showed similar efficacy and significantly fewer side effects than the standard treatment duration of eight weeks when compared to placebo, according to the results of a clinical trial in Bolivia led by the Drugs for Neglected Diseases initiative (DNDi). Chagas disease affects an estimated
Complete Reading

What is each partner looking to get? Credit: Africa Studio/Shutterstock.com “Show me the bodies!” someone demanded at the end of my lecture a few years ago. As a scholar of public health ethics, law and policy, I had just warned an audience of professors and university administrators about the perils of partnering with, or taking
Complete Reading

FREMONT, Calif., Feb. 21, 2019 (GLOBE NEWSWIRE) — Zosano Pharma Corporation (NASDAQ:ZSAN), a clinical-stage biopharmaceutical company, today announced the completion of the second and final goal of the long-term safety study for Qtrypta, in which patients treated migraine attacks over a one year period.  The long-term data generated in this trial reinforced the well-tolerated safety
Complete Reading

In a large UK population-based study, Ian Wong and colleagues at the University of Hong Kong and University College London, UK, found no statistically significant association between the antidepressant trazodone and a reduced risk of dementia when compared to other antidepressants. Their findings were published this week in PLOS Medicine. In vitro and animal studies
Complete Reading

(HealthDay)—Certain lots of Roche Diagnostics test strips should not be used with CoaguChek test meter devices to check levels of the blood thinner warfarin because patients may get inaccurate results and be at risk for serious injury or death, the U.S. Food and Drug Administration says in an updated recall notice. Last November, Roche recalled
Complete Reading

A study from investigators at the Massachusetts General Hospital (MGH) Institute for Technology Assessment projects that the opioid overdose epidemic in the U.S. is likely to increase in coming years, and that measures based on restricting access to prescription opioids will have a minimal impact in reducing overdose deaths. In their report published in JAMA
Complete Reading

A member of the family that owns OxyContin maker Purdue Pharma told people at the prescription opioid painkiller’s launch party in the 1990s that it would be “followed by a blizzard of prescriptions that will bury the competition,” according to court documents filed Tuesday. The details were made public in a case brought by Massachusetts
Complete Reading

A new report has revealed that patients in the north of the country are being prescribed almost four times more opioids to relieve pain than those in the south. The research by the University of Nottingham’s School of Pharmacy and the University of Manchester is the first national study to examine the regional variations in
Complete Reading

Create Account



Log In Your Account